Fleury Medicina e Saúde

Sao Paulo, Brazil Founded: 1926 • Age: 100 yrs
Medical diagnostic services are provided in Brazil by Fleury Group.
Request Access

About Fleury Medicina e Saúde

Fleury Medicina e Saúde is a company based in Sao Paulo (Brazil) founded in 1926. It operates as a Professional Services. The company has 22,900 employees as of December 31, 2024. Fleury Medicina e Saúde has completed 7 acquisitions, including Femme, Hospital Saha and Laboratório Pretti. Fleury Medicina e Saúde offers products and services including Diagnostic Exams and Vaccines. Fleury Medicina e Saúde operates in a competitive market with competitors including Roche, EKF, SonoSite, Cordant Health Solutions and NVision Imaging Technologies, among others.

  • Headquarter Sao Paulo, Brazil
  • Employees 22900 as on 31 Dec, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Fleury Sa
Operational Areas
Healthcare → Medical Devices & Diagnostics
Key Metrics
  • Annual Revenue
    $1.24 B (USD)
    18.76
    as on Dec 31, 2024
  • Net Profit
    $99.63 M (USD)
    45.41
    as on Dec 31, 2024
  • EBITDA
    $318.53 M (USD)
    25.3
    as on Dec 31, 2024
  • Latest Funding Round
  • Investors
  • Employee Count
    22900

    as on Dec 31, 2024

  • Investments & Acquisitions
    Femme

    & 6 more

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Fleury Medicina e Saúde

Fleury Medicina e Saúde is a publicly listed company on the BMFBOVESPA with ticker symbol FLRY3 in Brazil, operating in the Health services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: BMFBOVESPA · Ticker: FLRY3 . Sector: Health services · Brazil

Products & Services of Fleury Medicina e Saúde

Fleury Medicina e Saúde offers a comprehensive portfolio of products and services, including Diagnostic Exams and Vaccines. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Diagnostic exams are provided for accurate medical analysis.

Vaccination services are offered for preventive health care.

People of Fleury Medicina e Saúde
Headcount 5000-10000
Employee Profiles 10
Employee Profiles
People
Ana Carolina Eichner
Coordenadora Comercial
People
Jaime Jimenez
Consultor Em Gestão
People
Pedro Rodrigues Miranda
Tecnólogo Em Radiologia Medica
People
Mich Braga
Business & Operations Manager

Unlock access to complete

Funding Insights of Fleury Medicina e Saúde

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investments & Acquisitions by Fleury Medicina e Saúde

Fleury Medicina e Saúde has strategically engaged in corporate development activities, having acquired 7 companies. Notable acquisitions include Femme, Hospital Saha and Laboratório Pretti. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Healthcare management services are provided to organizations in Brazil.
2010
Multispecialty hospital services are provided standalone in Sao Paulo.
2004
Dental imaging services are provided by Papaiz Diagnósticos.
1996
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Fleury Medicina e Saúde

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Fleury Medicina E Saúde Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Fleury Medicina e Saúde

Fleury Medicina e Saúde operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Roche, EKF, SonoSite, Cordant Health Solutions and NVision Imaging Technologies, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Pharmaceuticals and diagnostics kits are developed for various diseases.
domain founded_year HQ Location
Point-of-care and laboratory blood analyzers are developed by EKF.
domain founded_year HQ Location
Hand-carried ultrasound systems for medical specialties are developed and distributed.
domain founded_year HQ Location
Drug testing services are offered for clinical trials and workplaces.
domain founded_year HQ Location
Medical imaging is provided through quantum technologies.
domain founded_year HQ Location
Cloud based diagnostics platform for point of care diagnosing
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Fleury Medicina E Saúde

Frequently Asked Questions about Fleury Medicina e Saúde

When was Fleury Medicina e Saúde founded?

Fleury Medicina e Saúde was founded in 1926.

Where is Fleury Medicina e Saúde located?

Fleury Medicina e Saúde is headquartered in Sao Paulo, Brazil.

How many employees does Fleury Medicina e Saúde have?

As of Dec 31, 2024, the latest employee count at Fleury Medicina e Saúde is 22,900.

What is the annual revenue of Fleury Medicina e Saúde?

Annual revenue of Fleury Medicina e Saúde is $1.24B as on Dec 31, 2024.

What does Fleury Medicina e Saúde do?

Fleury Medicina e Saúde is focused on providing diagnostic healthcare services in Brazil. The company operates as a reference laboratory, offering a range of medical exams, vaccinations, and personalized health solutions. Services are delivered through various units, catering to individual and family needs in the healthcare sector.

Who are the top competitors of Fleury Medicina e Saúde?

Fleury Medicina e Saúde's top competitors include Roche, EKF and LumiraDx.

What products or services does Fleury Medicina e Saúde offer?

Fleury Medicina e Saúde offers Diagnostic Exams and Vaccines.

Is Fleury Medicina e Saúde publicly traded?

Yes, Fleury Medicina e Saúde is publicly traded on BMFBOVESPA under the ticker symbol FLRY3.

How many acquisitions has Fleury Medicina e Saúde made?

Fleury Medicina e Saúde has made 7 acquisitions, including Femme, Hospital Saha, and Laboratório Pretti.

What is Fleury Medicina e Saúde's ticker symbol?

The ticker symbol of Fleury Medicina e Saúde is FLRY3 on BMFBOVESPA.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available